期刊文献+

淋巴结阴性乳腺癌p21^(waf1)、c-erbB-2和p53蛋白表达及其临床意义 被引量:5

Expression of p21^(waf1), c-erbB-2, and p53 Genes in Node-Negative Breast Carcinoma and Their Clinical Significance
下载PDF
导出
摘要 目的:探讨腋淋巴结阴性乳腺癌组织中p21waf1、c-erbB-2和p53基因蛋白表达及其与临床病理参数和预后的关系。方法:应用免疫组化LSAB方法检测121例腋淋巴结阴性乳腺癌石蜡切片中p21waf1、c-erbB-2和p53蛋白的表达情况;同时应用Kaplan-Meier法及多变量Cox比例风险模型,分析3种蛋白表达与预后的关系。结果:(1)p21waf1蛋白表达率为 48. 8%,与病理组织学分级、ER状态有关; p53蛋白表达率为 36. 4%, c-erbB-2蛋白表达率为 26. 4%,与组织学分级有关;(2)p21waf1阳性表达与 p53表达呈负相关( P< 0. 05);(3)p21waf1阳性组患者无瘤生存率高于阴性组(P<0.05);c-erbB-2阳性组患者无瘤生存率明显低于阴性组(P<0 01);Cox模型分析显示仅有c-erbB-2表达对预后有显著影响。结论:乳腺癌组织p21waf1、c-erbB-2表达与病理组织学分级有相关性;p21waf1表达依赖于p53途径刺激; p21waf1、、c-erbB-2表达与腋淋巴结阴性乳腺癌预后有关,且c-erbB-2表达是一个独立的预后指标。 Objective: The aim of this study was to determine the expression of p21waf1, c-erbB-2, and p53 in node-negative breast cancer in relation to the clinicopathological parameters and prognosis. Methods: Expression of p21waf1, c-erbB-2 and p53 in 121 patients were determined by LSAB immunohistochemical method, and Kaplan-Meter method and Cox proportional hazard model were used to analyze the relationship of their expressions with prognosis. Results: (1) The expression rate of p21waf1 was 48. 8% , and was in connection with histological grade and ER-positive. (2 ) The expression rate of p53 and c-erbB-2 was 36. 4% and 26. 4% respectively. C-erbB-2 positive expression was associated with histological grade. (3 ) the expression of p21waf1 was inversely correlated with that of p53 protein (P < 0. 05 ). (4) the results of survival analysis with Kaplan-Meter method showed that better disease-free survival(DFS) in the patients with p21waf1 expression than those without, the negative c-erbB-2 expression exhibited a significantly better prognosis than positive c-erbB-2 expression (P < 0. 01 ). Conclusions: There was a significant correlation between the expression of p21waf1, c-erbB-2, and tumor grade; a p53-indenpent pathway can mainly induce the expression of p21waf1; p21waf1 expression was a good prognostic marker for the patients with node-negative breast cancer; c-erbB- 2 positive expression was an independent prognostic marker.
出处 《癌症》 SCIE CAS CSCD 北大核心 2001年第6期631-634,共4页 Chinese Journal of Cancer
基金 广东省科委科研基金项目(99M04914G)
关键词 P21^WAF1 C-ERBB-2 p53 预后 乳腺肿国 临床意义 免疫组化 Breast carcinoma p21 waf1 c-erbB-2 p53 Prognosis
  • 相关文献

参考文献2

  • 1世界卫生组织.1997年世界卫生报告,第1版[M].北京:人民卫生出版社,1998.27-28. 被引量:1
  • 2世界卫生组织,1997年世界卫生报告,1998年,27页 被引量:1

同被引文献34

  • 1Harper JM,Adami GR,Wei N,et al. The P21 CDK--interacting protein Cipl is a potent inhibitor of G1 cycylin--dependent kinases[J]. Cell, 1993,75 :805. 被引量:1
  • 2Steven A. Ahrendt,Heather M. Brown,Rhchard A. Komorowski,et al. P21^WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer[J]. Surgery, 2000,128 (4) :520. 被引量:1
  • 3马祥君,王启堂,张永生,史光军,何洛文,梁宏立,王梅.乳腺癌 c-erbB-2、表皮生长因子受体基因蛋白表达与预后的关系[J].癌症,1997,16(2):111-113. 被引量:4
  • 4Chaudary MA,Millis RR,Hoskims EOL,et al.Bilateral primary breast cancer:a prospective study of disease incidence[J].Br J Surg,1984,71(9):711. 被引量:1
  • 5Safal M,Lower EE,Hasselgren PO,et al.Bilateral synchronous breast cancer and Her-2/neu overexpression[J].Breast Cancer Research and Treatment,2002,72(3):195. 被引量:1
  • 6Kinoshita T,Ueda M,Enomoto K,et al.Comparison of p53 gene abnormalities in bilateral and unilateral breast cancer[J].Cancer,1995,76(12):2504. 被引量:1
  • 7Heron DE,Komarnicky LT,Hyslop T,et al.Bilateral breast carcinoma:risk factors and outcomes for patients with synchronous and metachronous disease[J].Cancer,2000,88(12):2739. 被引量:1
  • 8左文述.双侧原发性乳腺癌18例报告[J].实用癌症杂志,1988,3(3):146-146. 被引量:1
  • 9Urban JA,Papachristou D,Taylor J.Bilateral breast cancer-biopsy of the opposite breast[J].Cancer,1977,40(4):1968. 被引量:1
  • 10Kollias J,Ellis IO,Elston CW,et al.Prognostic significance of synchronous and metachronous bilateral breast cancer[J].World J Surg,2001,25(9):1117. 被引量:1

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部